Related Experiment Video
Updated: Apr 1, 2026
07:48
Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
11.9K
Identification of thyroid tumor cell vulnerabilities through a siRNA-based functional screening
Maria Anania1, Fabio Gasparri2, Elena Cetti1
1Molecular Mechanisms Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Oncotarget
|October 3, 2015
Summary
Researchers identified new therapeutic targets for thyroid cancer by finding genes crucial for tumor cell survival but not normal cells. This discovery offers hope for developing effective treatments against aggressive thyroid carcinoma.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Thyroid carcinoma incidence is rising, with aggressive forms lacking effective treatments.
- Identifying novel therapeutic targets is crucial for overcoming treatment resistance in thyroid cancer.
Purpose of the Study:
- To discover genes essential for thyroid tumor cell survival but not normal cells (non-oncogene addiction).
- To identify potential new therapeutic targets for aggressive thyroid carcinoma.
Main Methods:
- Screened a siRNA library targeting the human druggable genome in thyroid cancer cells (BCPAP) and normal thyrocytes (Nthy-ori 3-1).
- Identified and validated key genes (Cyclin D1, MASTL, COPZ1) through silencing and assessing cell viability.
Main Results:
- Identified a panel of genes essential for thyroid tumor cell growth but not normal cell viability.
- Silencing Cyclin D1, MASTL, and COPZ1 reduced the viability of various thyroid tumor cell lines.
- These genes represent common vulnerabilities across different thyroid cancer types.
Conclusions:
- Discovered non-oncogenes critical for sustaining the thyroid tumor cell phenotype.
- These identified genes are promising therapeutic targets for novel thyroid cancer treatment strategies.
